Latest Updates
-
Maharashtra Day 2026: Why The State Of Bombay Split Into Two And How The Day Is Marked With Celebrations -
Vegetable Kurma Recipe: Experience South Indian Authentic Taste -
Home Cooling Tips Without An Air Conditioner This Summer – 6 Decor Solutions That Do The Trick! -
Sweet Spicy Street Style Honey Chilli Potato Recipe -
Beauty Hacks 101: 5 Easy Ways To Use Mango For Quick Summer Skin Fixes At Home -
Two Teachers Die On Census Duty In Odisha, Heatstroke Suspected: Why Summers Are Getting Harder To Survive -
Veg Fried Rice Recipe: Master the Wok Toss Restaurant Trick -
Samantha Ruth Prabhu Birthday Special: 7 Outfits That Redefined ‘The Family Man 2’ Star’s Power Dressing -
Hidden Signs Of Insulin Resistance: What Your Body Is Trying To Tell You -
Soft Coastal Style Neer Dosa Recipe: A Breakfast Delight
Biological E Ltd To Get mRNA Technology From WHO To Produce Covid-19 Vaccines
City-based vaccine maker Biological E. Limited on Monday said the company was selected as a recipient of mRNA technology to produce COVID-19 vaccines from the World Health Organisation.

A press release from BE Limited said the WHO's Advisory Committee on Vaccine Product Development (ACPDV) selected the firm after examining a number of proposals from India, as a recipient of mRNA (ribonucleic acid) technology from the global health body's technology transfer hub.
Mahima Datla, Managing Director, BE Ltd said: "BE has been investing in mRNA technologies since last year. This new technology will definitely strengthen our resolve to develop and manufacture more vaccines in future. This partnership with WHO will enhance our ability to develop next-generation mRNA vaccines that could be more suitable globally and expand the reach of vaccines availability worldwide.''
WHO and their partners will work with the Indian government and Biological E to develop a roadmap and put in place the necessary training and support for the vaccine maker to start producing mRNA vaccines as soon as possible.
Primarily set up to address the COVID-19 emergency, the WHO mRNA technology transfer hub has the potential to expand manufacturing capacity for other products as well, including treatments, and target other priorities.
mRNA vaccines use a messenger RNA created in a laboratory to teach the human cells how to produce a protein that in turn initiates an immune response inside the body against a particular disease. The immune response will fight the actual virus as it gets into the body.
At present, India has no COVID-19 vaccine made on an mRNA platform.
Last month, the Centra had given approval for Biological E's Corbevax to be administered to the 12-14 years age group across the country.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications